Cargando…
COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility
Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) raises concerns as to whether it contributes to an increased mortality. The incidence of CAPA varies widely within hospitals and countries, partly because of difficulties in obtaining a reliable diagnosis. We implemented a...
Autores principales: | Lackner, Nina, Thomé, Claudius, Öfner, Dietmar, Joannidis, Michael, Mayerhöfer, Timo, Arora, Rohit, Samardzic, Eldina, Posch, Wilfried, Breitkopf, Robert, Lass-Flörl, Cornelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875712/ https://www.ncbi.nlm.nih.gov/pubmed/35205848 http://dx.doi.org/10.3390/jof8020093 |
Ejemplares similares
-
A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data
por: Lass-Flörl, Cornelia, et al.
Publicado: (2022) -
Evaluation of Inoculum Preparation for Etest and EUCAST Broth Dilution to Detect Anidulafungin Polyresistance in Candida glabrata
por: Knoll, Miriam Alisa, et al.
Publicado: (2022) -
Microbiological and Molecular Diagnosis of Mucormycosis: From Old to New
por: Lackner, Nina, et al.
Publicado: (2021) -
Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature
por: Mayr, A, et al.
Publicado: (2011) -
Diagnostic Performance of a Novel Multiplex PCR Assay for Candidemia among ICU Patients
por: Fuchs, Stefan, et al.
Publicado: (2019)